Sofia Haque
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
-
- Thyroid Cancer Diagnosis and Treatment
Papers in
- Co-authors
- David G. Pfister (46 shared papers)Eric J. Sherman (44 shared papers)Alan L. Ho (33 shared papers)Matthew G. Fury (27 shared papers)Ronglai Shen (10 shared papers)Pat Zanzonico (12 shared papers)Steven M. Larson (10 shared papers)Nora Katabi (19 shared papers)
- Journals
- Journal of Clinical Oncology (31 papers)Neuro-Oncology (7 papers)Cancer (6 papers)Pediatric Blood & Cancer (5 papers)Annals of Oncology (4 papers)
- Partner nations
- United StatesIndiaBelarus
In The Last Decade
Sofia Haque
89 papers receiving 2.5k citations
Sofia Haque's Hit Papers
Peers
Comparison fields: 5 of 93
- Otorhinolaryngology 179
- Endocrinology, Diabetes and Metabolism 616
- Genetics 349
- Oncology 721
- Neurology 316
Countries citing papers authored by Sofia Haque
This map shows the geographic impact of Sofia Haque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Haque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Haque more than expected).
Fields of papers citing papers by Sofia Haque
This network shows the impact of papers produced by Sofia Haque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Haque. The network helps show where Sofia Haque may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofia Haque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer Hit paper breakdown → | 2013 | 566 |
| 2 | 2018 | 212 | |
| 3 | 2019 | 147 | |
| 4 | 2016 | 87 | |
| 5 | 1998 | 79 | |
| 6 | Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). | 2011 | 64 |
| 7 | 2012 | 63 | |
| 8 | 2012 | 61 | |
| 9 | 2012 | 58 | |
| 10 | 2017 | 58 | |
| 11 | 2017 | 54 | |
| 12 | 2019 | 54 | |
| 13 | 2016 | 50 | |
| 14 | 2018 | 49 | |
| 15 | 2008 | 48 | |
| 16 | 2017 | 46 | |
| 17 | 2013 | 46 | |
| 18 | 2011 | 45 | |
| 19 | 2016 | 44 | |
| 20 | 2017 | 37 |
About Sofia Haque
Sofia Haque is a scholar working on Genetics, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 97 papers that have together received 2.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (23 papers), Thyroid Cancer Diagnosis and Treatment (15 papers), Radiopharmaceutical Chemistry and Applications (12 papers), Head and Neck Cancer Studies (11 papers), Neuroblastoma Research and Treatments (9 papers), Lung Cancer Treatments and Mutations (9 papers), Salivary Gland Tumors Diagnosis and Treatment (8 papers) and Brain Metastases and Treatment (7 papers). The work is most often cited by research in Otorhinolaryngology (179 citations), Endocrinology, Diabetes and Metabolism (616 citations), Genetics (349 citations), Oncology (721 citations) and Neurology (316 citations). Sofia Haque has collaborated with scholars based in United States, India and Belarus. Frequent co-authors include David G. Pfister, Eric J. Sherman, Alan L. Ho, Matthew G. Fury, Ronglai Shen, Pat Zanzonico, Steven M. Larson, Nora Katabi, Ronald Ghossein and Shrujal S. Baxi. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Cancer, Pediatric Blood & Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.